Exane Derivatives acquired a new stake in shares of Lam Research Co. (NASDAQ:LRCX) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 12,812 shares of the semiconductor company’s stock, valued at approximately $2,358,000.
Other hedge funds and other institutional investors have also modified their holdings of the company. Signature Estate & Investment Advisors LLC lifted its holdings in shares of Lam Research by 15.2% in the 3rd quarter. Signature Estate & Investment Advisors LLC now owns 3,986 shares of the semiconductor company’s stock worth $738,000 after purchasing an additional 527 shares during the last quarter. Putnam FL Investment Management Co. bought a new stake in shares of Lam Research in the 3rd quarter worth approximately $15,390,000. Epoch Investment Partners Inc. lifted its holdings in shares of Lam Research by 0.9% in the 3rd quarter. Epoch Investment Partners Inc. now owns 64,708 shares of the semiconductor company’s stock worth $11,974,000 after purchasing an additional 600 shares during the last quarter. Financial Enhancement Group LLC bought a new stake in shares of Lam Research in the 3rd quarter worth approximately $295,000. Finally, 361 Capital LLC lifted its holdings in shares of Lam Research by 55.6% in the 2nd quarter. 361 Capital LLC now owns 30,606 shares of the semiconductor company’s stock worth $4,329,000 after purchasing an additional 10,938 shares during the last quarter. Hedge funds and other institutional investors own 92.49% of the company’s stock.
In other Lam Research news, insider Martin B. Anstice sold 21,955 shares of the business’s stock in a transaction dated Friday, November 17th. The stock was sold at an average price of $211.16, for a total value of $4,636,017.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Seshasayee Varadarajan sold 25,453 shares of the business’s stock in a transaction dated Tuesday, January 23rd. The stock was sold at an average price of $215.00, for a total value of $5,472,395.00. The disclosure for this sale can be found here. Insiders sold 56,722 shares of company stock valued at $12,088,028 in the last ninety days. Insiders own 0.41% of the company’s stock.
Shares of Lam Research Co. (NASDAQ LRCX) opened at $172.95 on Tuesday. The stock has a market capitalization of $28,010.00, a price-to-earnings ratio of 19.05, a P/E/G ratio of 0.67 and a beta of 1.47. Lam Research Co. has a 12-month low of $113.20 and a 12-month high of $219.70. The company has a current ratio of 2.47, a quick ratio of 2.09 and a debt-to-equity ratio of 0.29.
Lam Research (NASDAQ:LRCX) last released its quarterly earnings data on Wednesday, January 24th. The semiconductor company reported $4.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.68 by $0.66. The firm had revenue of $2.58 billion during the quarter, compared to analysts’ expectations of $2.57 billion. Lam Research had a return on equity of 36.08% and a net margin of 17.60%. The business’s revenue for the quarter was up 37.1% on a year-over-year basis. During the same quarter last year, the firm earned $2.24 earnings per share. equities analysts forecast that Lam Research Co. will post 16.74 EPS for the current year.
Lam Research declared that its board has authorized a stock repurchase program on Tuesday, November 14th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the semiconductor company to reacquire shares of its stock through open market purchases. Shares buyback programs are often a sign that the company’s board believes its shares are undervalued.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 28th. Shareholders of record on Wednesday, March 7th will be given a $0.50 dividend. The ex-dividend date is Tuesday, March 6th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.16%. Lam Research’s dividend payout ratio is currently 22.03%.
LRCX has been the topic of several recent research reports. Vetr downgraded Lam Research from a “buy” rating to a “hold” rating and set a $196.77 price target on the stock. in a report on Monday, October 16th. B. Riley lifted their target price on Lam Research from $220.00 to $250.00 and gave the company a “buy” rating in a research note on Monday, October 16th. DA Davidson reaffirmed a “buy” rating on shares of Lam Research in a research note on Wednesday, October 18th. Stifel Nicolaus lifted their target price on Lam Research from $215.00 to $235.00 and gave the company a “buy” rating in a research note on Wednesday, October 18th. Finally, Royal Bank of Canada lifted their target price on Lam Research from $185.00 to $210.00 and gave the company an “outperform” rating in a research note on Wednesday, October 18th. Two equities research analysts have rated the stock with a hold rating, twenty-three have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $232.41.
ILLEGAL ACTIVITY WARNING: “Exane Derivatives Takes Position in Lam Research Co. (LRCX)” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/13/exane-derivatives-buys-shares-of-12812-lam-research-co-lrcx.html.
About Lam Research
Lam Research Corporation is a supplier of wafer fabrication equipment and services to the semiconductor industry. The Company designs, manufactures, markets, refurbishes and services semiconductor processing systems that are used in the fabrication of integrated circuits (ICs). It operates through manufacturing and servicing of wafer processing semiconductor manufacturing equipment segment.
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.